CRNX
Crinetics Pharmaceuticals, Inc. · Healthcare
Chief Med, Dev Officer Dana Pizzuti sold $785K of Crinetics Pharmaceuticals, Inc.
Sold$785,306
$54.63Price
14,375Shares
−34%Stake
What CRNX did after the filing
- The stock from Mon, Oct 7 open, $53.23
- +0.9%
- S&P 500, same days
- +2.9%
Measured over 30 trading days, to the Nov 18 close.
Traded Thu, Oct 3. Filed Mon, Oct 7, 3:55 AM ET, before the open. Returns use the Oct 7 open and the Nov 18 close. Not investment advice.